Everus (NYSE:ECG) Given New $80.00 Price Target at Oppenheimer

Everus (NYSE:ECGGet Free Report) had its price objective boosted by analysts at Oppenheimer from $70.00 to $80.00 in a report released on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s price target would suggest a potential upside of 18.24% from the company’s previous close.

Several other equities research analysts have also weighed in on ECG. Wolfe Research assumed coverage on Everus in a research note on Tuesday, December 3rd. They set a “peer perform” rating for the company. DA Davidson assumed coverage on Everus in a research note on Monday, November 4th. They set a “neutral” rating and a $55.00 price objective for the company. Finally, Stifel Nicolaus raised their price objective on Everus from $71.00 to $78.00 and gave the stock a “buy” rating in a research note on Wednesday, December 11th.

Read Our Latest Research Report on ECG

Everus Stock Down 1.9 %

Shares of NYSE ECG opened at $67.66 on Tuesday. The firm’s fifty day moving average price is $64.86. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.58 and a quick ratio of 1.50. Everus has a 1 year low of $40.05 and a 1 year high of $73.73.

Everus Company Profile

(Get Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Read More

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.